Just a stray thought. Of what company is "the scum" a CEO? Some of the following might get a bit complicated. Hold on for the ride.
I call Vivek Ramaswamy "the scum" because of his memorable exchange with Nikki Haley. He said she should keep her daughter off TikTok. She said he should keep her daughter "out of your voice," sounding a bit like Will Smith to Chris Rock. He returned to his trollish ways and she muttered "you're just scum". So he has a moniker for the ages. It looked like he was lucky she didn't ChrisRock his world.
Still, that exchange is not my stray thought for today. I am wondering about the several times he said he would be a great President because he is a CEO.
The Republicans DID have a successful CEO as a candidate for President not long ago. His name was Mitt Romney. His party is rather on the outs with him now.
The scum was never the CEO of a Bain Capital. He was the CEO of Roivant Sciences, a Bermuda incorporated pharmaceutical concern with a distinctive strategy. Roivant was in the business of purchasing patents from larger biotech firms -- patents for pharma products where the research work has been done but where they have not yet been brought to market.
Let's think about this for a moment. You regularly walk past the yard of a neighbor of yours who has more money and better cars than you do. One day you walk past and see a car on the front yard with a sign on it that says, "Car for sale AS IS -- $1,000." Do you want to buy it? The success of Roivant (where "ROI" is said to stand for "return on investment") depends on its ability to buy some such cars in such a condition that they are worth more to it than the $1K purchase price.
But if the Big Pharma concern knows this IP is worth more than its purchase price, why is it offering to for sale? Why can it not bring this car to market itself? Hold that thought. Yes, obviously Roivant is making a risky bet in any such case and it is unsurprising that Roivant has NEVER recorded a profitable year.
What is more puzzling: VR seems to have made most of his personal wealth due to his interest in a company spun off from Roivant, called Axovant. Axovant was a one-trick pony -- it bet everything on the utility of a chemical compound called intepirdine, a treatment for Alzheimer's.
Before clinical trials began, experts were optimistic about intepirdine and VR engineered an initial public offering in Axovant. Axovant's market value soared to nearly $3 billion on optimism. VR sold a portion of his shares almost immediately after the IPO and, voila, a fortune sufficient to finance a presidential campaign was born.
A moment ago, describing the Roivant business plan, I was imagining Roivant as the guy who buys cars AS IS. A risky decision. But in the case of VR's personal decisions with his Axovant stock, VR is on the other side. He is the one trying to sell the car. And he did successfully sell the car, for much more than it was actually worth. He used intepirdine optimism to make a fortune off Axovant.
What happened next? Well ... the buyers of this "car" found they had bought a lemon. Intepirdine failed its clinical trial. The company stock lost 75% of its value as soon as this result was announced. Axovant hobbled a long for a few years. It re-branded itself as a gene therapy concern in 2020. That didn't work either, and the company dissolved formally in April 2023.
I wouldn't necessarily infer from any of this that VR did anything wrong, much less illegal. Still, the savvy necessary to set up a money-loser like Roivant in order then to create a subsidiary like Axovant in order then to pump up the value of its shares on a speculative medical breakthrough, in order then to sell into the optimism and reap a fortune just before the price collapses -- the acumen to do all that is not necessarily part of the skill set of a desirable President.
Comments
Post a Comment